Company intelligence / Profile preview

FREDsense Technologies

Ownership: Private
Employees: ~24
Development stage: Commercial

Overview

FREDsense Technologies has developed rapid, field-deployable solutions for detecting PFAS and other contaminants in water. Their technology enables same-day results with lab-grade precision, validated against EPA methods. They offer both analytical services using LC-MS/MS instrumentation as well as portable kits that can detect up to 40 PFAS analytes at part-per-trillion levels. Their solutions have been successfully deployed in real-world scenarios such as airport remediation projects.

Modalities: DeviceBiosensor (Biologic)
Industry: Non-Drug Biotech

Partnerships

TRS Group – collaboration on AFFF changeout/cleanup at airports using the FRED-PFAS system.Other partnerships include municipalities, utilities, consultants, technology developers.

Beyond the preview

Go deeper on FREDsense Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on FREDsense Technologies.

Explore the full profile